title: Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.
authors.forename: P M
authors.initials: PM
authors.lastname: Fracasso
authors.forename: B R
authors.initials: BR
authors.lastname: Tan
authors.forename: M
authors.initials: M
authors.lastname: Grieff
authors.forename: J
authors.initials: J
authors.lastname: Stephenson
authors.forename: H
authors.initials: H
authors.lastname: Liapis
authors.forename: N L
authors.initials: NL
authors.lastname: Umbeck
authors.forename: D D
authors.initials: DD
authors.lastname: Von Hoff
authors.forename: E K
authors.initials: EK
authors.lastname: Rowinsky
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001996:Bronchopneumonia / Q000150:complications; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D017809:Fatal Outcome; D015432:Glomerulonephritis, Membranoproliferative / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy*; D010534:Peritoneal Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D003841:Deoxycytidine; D014747:Vinblastine; D000077235:Vinorelbine; D000093542:Gemcitabine